CONCI, NICOLE

CONCI, NICOLE  

Mostra records
Risultati 1 - 10 di 10 (tempo di esecuzione: 0.023 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Ad(aura): a fresh breeze for patients with resected EGFR-mutant non-small cell lung cancer Conci N.; De Giglio A.; Sperandi F.; Melotti B.; Gelsomino F. 2024-01-01 CHINESE CLINICAL ONCOLOGY - 1.01 Articolo in rivista -
First-Generation Epidermal Growth Factor Receptor Inhibitors Plus Antiangiogenic Drugs Versus Third-Generation Epidermal Growth Factor Receptor Inhibitors in Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis Mosca, Mirta; Conci, Nicole; Di Federico, Alessandro; Tateo, Valentina; Favorito, Valentina; Zapp...i, Arianna; Gelsomino, Francesco; De Giglio, Andrea 2023-01-01 JCO PRECISION ONCOLOGY - 1.01 Articolo in rivista -
How Do Molecular Classifications Affect the Neoadjuvant Treatment of Muscle-Invasive Urothelial Carcinoma? Conci, Nicole; Tassinari, Elisa; Tateo, Valentina; Rosellini, Matteo; Marchetti, Andrea; Ricci, C...ostantino; Chessa, Francesco; Santoni, Matteo; Grande, Enrique; Mollica, Veronica; Massari, Francesco 2023-01-01 MOLECULAR DIAGNOSIS & THERAPY - 1.01 Articolo in rivista Molecular Diagn Ther 2023 [Neoadj UC].pdf
Metabolic pseudoprogression in a patient with metastatic KIT exon 11 GIST after 1 month of first-line imatinib: a case report Elisa Tassinari, Nicole Conci, Giacomo Battisti, Francesco Porta, Valerio Di Scioscio, Maria Giul...ia Pirini, Dario de Biase, Maria Concetta Nigro, Miriam Iezza, Fausto Castagnetti, Luigi Lovato, Stefano Fanti, Maria Abbondanza Pantaleo, Margherita Nannini 2023-01-01 FRONTIERS IN ONCOLOGY - 1.01 Articolo in rivista Tassinari, Conci Front Oncol 2023.pdf
Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC Dall'Olio, Filippo G; Parisi, Claudia; Marcolin, Laura; Brocchi, Stefano; Caramella, Caroline; Co...nci, Nicole; Carpani, Giulia; Gelsomino, Francesco; Ardizzoni, Stefano; Marchese, Paola Valeria; Paccapelo, Alexandro; Grilli, Giada; Golfieri, Rita; Besse, Benjamin; Ardizzoni, Andrea 2022-01-01 THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY - 1.01 Articolo in rivista 12. Dall'Olio_Monitoring Tumor Growth Rate to predict Immune Checkpoint Inhibitors’ treatment outcome in advanced NSCLC.pdf
Baseline total metabolic tumour volume on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography-computed tomography as a promising biomarker in patients with advanced non-small cell lung cancer treated with first-line pembrolizumab. Dall'Olio FG, Calabrò D, Conci N, Argalia G, Marchese PV, Fabbri F, Fragomeno B, Ricci D, Fanti S..., Ambrosini V, Ardizzoni A. 2021-01-01 EUROPEAN JOURNAL OF CANCER - 1.01 Articolo in rivista -
PD-(L)1 inhibitors as single-agent or in combination with chemotherapy for advanced, PD-L1-high non-small cell lung cancer: a meta-analysis Di Federico A.; De Giglio A.; Nuvola G.; Deiana C.; Conci N.; Gelsomino F.; Ardizzoni A. 2021-01-01 FUTURE ONCOLOGY - 1.01 Articolo in rivista -
PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non–small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors Dall'Olio F.G.; Gelsomino F.; Conci N.; Marcolin L.; De Giglio A.; Grilli G.; Sperandi F.; Fontan...a F.; Terracciano M.; Fragomeno B.; Tober N.; Manferrari G.; Brocchi S.; Golfieri R.; Fiorentino M.; Ardizzoni A. 2021-01-01 CLINICAL LUNG CANCER - 1.01 Articolo in rivista -
Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients – A single centre experience Dall'Olio F.G.; Conci N.; Rossi G.; Fiorentino M.; De Giglio A.; Grilli G.; Altimari A.; Gruppion...i E.; Filippini D.M.; Di Federico A.; Nuvola G.; Ardizzoni A. 2020-01-01 LUNG CANCER - 1.01 Articolo in rivista -
The EGFR exon 19 mutant L747-A750>P exhibits distinct sensitivity to tyrosine kinase inhibitors in lung adenocarcinoma—letter Di Federico A.; Filippini D.M.; Dall'Olio F.G.; Conci N.; Minari R.; Tiseo M.; Ardizzoni A. 2020-01-01 CLINICAL CANCER RESEARCH - 1.01 Articolo in rivista -